Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase.

Han-Ah Lee Hyun Woong Lee In Hee Kim Soo-Young Park Dong Hyun Sinn Jung Hwan Yu Yeon Seok Seo Soon Ho Um Joung Il Lee Kwan Sik Lee Chang-Hun Lee Won Young Tak Young Oh Kweon Won Seok Kang Yong-Han Paik Young-Joo Jin Sang Jun Suh Young-Kul Jung Beom Kyung Kim Jun Yong Park Do Young Kim Sang Hoon Ahn Kwang-Hyub Han Hyung Joon Yim Seung-Up Kim

Published in: Alimentary pharmacology & therapeutics (2020)

The criterion of HBV-DNA level > 107 IU/mL may be useful to define immune-tolerant phase. In addition, an extremely low risk of HCC development was observed in patients with CHB in immune-tolerant phase.

Keyphrases

hepatitis b virus
single molecule
liver failure
liver fibrosis
nucleic acid